The FDA has approved ZTlido to relieve pain associated with postherpetic neuralgia.
The FDA has approved a treatment for 2 neuropathic pain conditions.
PNS can be beneficial for chronic intractable pain secondary to postherpetic neuralgia.
Patients suffering from postherpetic nearalgia found relief taking gabapentin.
Strategies to decrease risk of contracting varicella zoster virus need to be addressed in populations with autoimmune disease.
Patients who received LLLT within 5 days of herpes zoster eruption had a significantly reduced incidence of PHN.
At 6 months after the intervention, the patient reported a significant reduction in pain score.
Quality of sleep and pain intensity improved over the 8-week treatment period.
People with asthma are at an increased risk of shingles, which can lead to painful postherpetic neuralgia.
Chance of stroke and myocardial infarction increased most in the first week after diagnosis.
Herpes zoster reactivation can cause shingles.
The findings suggest that anti-cytokine immunodeficiency may contribute to development of PHN.
There is not enough evidence to support gabapentin's use as a primary headache treatment.
The researchers recommend that older adults be vaccinated to prevent long-term complications of shingles.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans